최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Regulatory peptides, v.98 no.1/2, 2001년, pp.69 - 75
Qu, Song-Yi (Corresponding author. Present address: Department of Physiology, Lanzhou Medical College, Gansu Province, People’) , Yang, Ying-Kui (s Republic of China) , Li, Ji-Yao (Department of Surgery, University of Michigan, Ann Arbor, MI 48109, USA) , Zeng, Qun (Department of Surgery, University of Michigan, Ann Arbor, MI 48109, USA) , Gantz, Ira (Department of Surgery, University of Michigan, Ann Arbor, MI 48109, USA)
AbstractTo explore the role of agouti-related protein (AGRP) in diabetic hyperphagia changes in hypothalamic AGRP mRNA levels were examined in diabetic rats. Rats rendered diabetic by streptozotocin displayed marked hyperglycemia (blood glucose 456.0±8.4 mg/dl versus 71.8±1.9 mg/dl) an...
Peptides McKibbin 13 721 1992 10.1016/0196-9781(92)90178-6 Insulin deficiency is a specific stimulus to hypothalamic neuropeptide Y: a comparison of the effects of insulin replacement and food restriction in streptozocin-diabetic rats
Diabetologia Marks 36 497 1993 10.1007/BF02743264 Effects of streptozotocin-induced diabetes mellitus and insulin treatment on neuropeptide Y mRNA in the rat hypothalamus
Diabetes Sipols 44 147 1995 10.2337/diabetes.44.2.147 Effect of intracerebroventricular insulin infusion on diabetic hyperphagia and hypothalamic neuropeptide gene expression
Diabetes Sindelar 48 1275 1999 10.2337/diabetes.48.6.1275 Low plasma leptin levels contribute to diabetic hyperphagia in rats
Am. J. Physiol. Kim 276 R1320 1999 STZ-induced diabetes decreases and insulin normalizes POMC mRNA in arcuate nucleus and pituitary in rats
Diabetes Havel 49 244 2000 10.2337/diabetes.49.2.244 Effects of streptozotocin-induced diabetes and insulin treatment on the hypothalamic melanocortin system and muscle uncoupling protein 3 expression in rats
Nature Schwartz 404 661 2000 10.1038/35007534 Central nervous system control of food intake
Am. J. Physiol. Levine R1223 1999 Brain glucose sensing and body energy homeostasis: role in obesity and diabetes
Genes Develop. Shutter 11 593 1997 10.1101/gad.11.5.593 Hypothalamic expression of ART, a novel gene related to agouti, is up-regulated in obese and diabetic mutant mice
Biochem. Biophys. Res. Commun. Fong 237 629 1997 10.1006/bbrc.1997.7200 ART (protein product of agouti-related transcript) as an antagonist of MC-3 and MC-4 receptors
Science Ollmann 278 135 1997 10.1126/science.278.5335.135 Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein
Biochem. Biophys. Res. Commun. Harold 258 574 1999 10.1006/bbrc.1999.0675 Changes in hypothalamic agouti-related protein (AGRP), but not α-MSH or pro-opiomelanocortin concentrations in dietary-obese and food-restricted rats
Diabetes Kim 49 177 2000 10.2337/diabetes.49.2.177 Hypothalamic localization of the feeding effect of agouti-related peptide and α-melanocyte-stimulating hormone
Nature Neurosci. Hahn 1 271 1998 10.1038/1082 Coexpression of AGRP and NPY in fasting-activated hypothalamic neurons
Mol. Endocrinol. Yang 13 148 1999 10.1210/me.13.1.148 Characterization of agouti-related protein binding to melanocortin receptors
J. Neurosci. Grill 18 10128 1998 10.1523/JNEUROSCI.18-23-10128.1998 Brainstem application of melanocortin receptor ligands produces long-lasting effects on feeding and body weight
Endocrinology Wilson 140 2387 1999 10.1210/en.140.5.2387 Physiological and anatomical circuitry between agouti-related protein and leptin signaling
Endocrinology Mizuno 140 814 1999 10.1210/en.140.2.814 Hypothalamic agouti-related protein messenger ribonucleic acid is inhibited by leptin and stimulated by fasting
Diabetes Ebihara 48 2028 1999 10.2337/diabetes.48.10.2028 Involvement of agouti-related protein, an endogenous antagonist of hypothalamic melanocortin receptor in leptin action
Endocrinology Li 141 1942 2000 10.1210/en.141.6.1942 Agouti-related protein-like immunoreactivitiy: characterization of release from hypothalamic tissue and presence in serum
Endocrinology Marks 127 3234 1990 10.1210/endo-127-6-3234 Localization of insulin receptor mRNA in rat brain by in situ hybridization
Prog. Neurobiol. Unger 36 343 1991 10.1016/0301-0082(91)90015-S Insulin receptors in the central nervous system: localization, signalling mechanisms and functional aspects
Endocrinology Schwartz 128 2645 1991 10.1210/endo-128-5-2645 Central insulin administration reduces neuropeptide Y mRNA expression in the arcuate nucleus of food-reprived lean (Fa/Fa) but not obese (fa/fa) zucker rats
Endocrinology Schwartz 130 3608 1992 10.1210/en.130.6.3608 Inhibition of hypothalamic neuropeptide Y gene expression by insulin
Endocrinology Sahu 136 5718 1995 10.1210/en.136.12.5718 Insulin and insulin-like growth factor II suppress neuropeptide Y release from the nerve terminals in the paraventricular nucleus: a putative hypothalamic site for energy homeostasis
Endocrinology Sahu 131 2979 1992 10.1210/en.131.6.2979 Neuropeptide Y release from the paraventricular nucleus increases in association with hyperphagia in streptozotocin-induced diabetic rats
Brain Res. Sahu 755 339 1997 10.1016/S0006-8993(97)00192-3 Evidence that hypothalamic neuropeptide Y gene expression and NPY levels in the paraventricular nucleus increase before the onset of hyperphagia in experimental diabetes
Mol. Cell. Biochem. Goldfine 153 217 1995 10.1007/BF01075941 In vivo and in vitro studies of vanadate in human and rodent diabetes mellitus
Diabetes Shechter 39 1 1990 10.2337/diabetes.39.1.1 Insulin-mimetic effects of vanadate, possible implications for future treatment of diabetes
Science Elchebly 283 1544 1999 10.1126/science.283.5407.1544 Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene
Biochem. Pharm. Kennedy 60 877 2000 10.1016/S0006-2952(00)00305-1 Protein tyrosine phosphatase-1B in diabetes
Eur. J. Endocrinol. Wauters 143 293 2000 10.1530/eje.0.1430293 Human leptin: from an adipocyte hormone to an endocrine mediator
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.